Neurology·Nashville, TN

HCA Healthcare/TriStar Nashville/Skyline Medical Center

Signal lift34%74%+40 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
228–257
p10 – p90
Sample N
292
applicants this cycle
This cycle
no tracked aways yet
Match rate
1.4%
4 of 73 applicants
01Cohort funnelthis cycle
N = 292
Applied
292
100.0%
Invited
73
25%
Class size
4
1.4%
J-1 visaAdvanced
Your fitHCA Healthcare/TriStar Nashville/Skyline Medical Center Program

Create a free profile to see your personalized fit

Get started
Contact
JW
Program Director
John Curtis Witt, MD, MS
Email director
SW
Program Coordinator
Sarah Wills, MD
Email coordinator
Training sites5 hospitals
  • 1
    TriStar Skyline Medical Center
    Nashville, TN
    Primary
  • 2
    HCA Healthcare/TriStar Nashville
    Brentwood, TN
    Sponsor
  • 3
    TriStar StoneCrest Medical Center
    Smyrna, TN
    Participant
  • 4
    TriStar Centennial Medical Center
    Nashville, TN
    Participant
  • 5
    TriStar Summit Medical Center
    Hermitage, TN
    Participant
Score rangesinvited cohort
USMLE Step 2 CK228257
180205230255280
COMLEX Level 2 CE477608
400500600700800
Interview rates
US MD
67%
US DO
50%
US IMG
6%
Non-US IMG
1%
Applicant origin
In-state
55%
Out-of-state
24%
Interview prepNeurology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesNeurology · 25-26
Save this program

Add HCA Healthcare/TriStar Nashville/Skyline Medical Center to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Neurology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.